|  | |  |  | Ambrisentan Impurity E Basic information | 
 | Product Name: | Ambrisentan Impurity E |  | Synonyms: | 2-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-3,3-diphenyl-2-propenoic Acid;Ambrisentan Impurity 10;2-(4,6-dimethylpyrimidin-2-yl)oxy-3,3-diphenylprop-2-enoic acid;Ambrisentan Impurity 11;2-Propenoic acid, 2-[(4,6-dimethyl-2-pyrimidinyl)oxy]-3,3-diphenyl- |  | CAS: | 1312092-82-2 |  | MF: | C21H18N2O3 |  | MW: | 346.38 |  | EINECS: |  |  | Product Categories: |  |  | Mol File: | 1312092-82-2.mol |  |  | 
|  |  | Ambrisentan Impurity E Chemical Properties | 
 | Melting point | >104°C (dec.) |  | storage temp. | Amber Vial, -20°C Freezer, Under inert atmosphere |  | solubility | DMSO (Slightly), Methanol (Slightly) |  | form | Solid |  | color | White to Off-White |  | Stability: | Light Sensitive | 
|  |  | Ambrisentan Impurity E Usage And Synthesis | 
 | Uses | 2-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-3,3-diphenyl-2-propenoic Acid is an acrylic acid derivative that can be used as an endothelin receptor antagonist useful for treating hypertension or pulmonary artery hypertension. Ambrisentan Impurity E | 
|  |  | Ambrisentan Impurity E Preparation Products And Raw materials | 
 |